Skip to main content

AI-derived oocyte morphology and follicular fluid biomarkers in donors

Journal
Reproduction (Cambridge, England) (Q1)
Published
29 July 2026
Study design
Unclassified
Evidence level
Level 5, Expert Opinion (CEBM 5)
Authors
Yamila Herrero, Candela Velázquez, Melanie Neira, Romina Criscione, Mariano Lavolpe, Dalhia Abramovich, et al.
PMID
42523187
DOI
10.1093/reprod/xaag092

Why clinicians should know about it

  • Picked for Embryology (paper of the day, 30 July 2026).

Abstract

Oocyte quality is a key determinant of reproductive success, yet its assessment in assisted reproduction largely relies on subjective morphological criteria. Artificial intelligence (AI)-based image analysis has introduced greater objectivity into oocyte evaluation; however, the biological features captured by AI-derived morphological scores remain incompletely defined. In this study, we integrated AI-based oocyte morphology with molecular profiling of follicular fluid (FF) to identify biological correlates of oocyte competence. Reproductive outcomes were analysed in 49 young oocyte donors (20-33 years), while FF samples pooled per woman from a subset of 25 donors were analysed for metabolic (glucose, total cholesterol, triglycerides, HDL, LDL, APOA1), extracellular matrix-related (HSPG2/Perlecan), signaling-related (Gremlin-1), and fertility-related (AMH, LH, FSH) biomarkers. AI-derived oocyte quality scores were positively associated with specific intrafollicular markers, including glucose, total cholesterol, HDL, AMH, and HSPG2, while no associations were observed with triglycerides, LDL, Gremlin-1, LH, or FSH. APOA1 showed a positive trend with the AI score. These findings provide a biological context for AI-based oocyte morphological assessment by linking digital image-derived scores with metabolic and structural features of the follicular microenvironment. The integration of AI-driven morphology with donor follicular fluid biomarker profiling may contribute to the development of more objective and biologically informed approaches for oocyte quality evaluation in assisted reproduction.

Abstract as published, via PubMed.

View on PubMedFull text at the publisherOpen in the app

For healthcare professionals. The summary is generated by AI from the published abstract, and the evidence level is assigned automatically from the study design on the Oxford CEBM hierarchy. Neither is medical advice. Read the full paper before changing practice.